BioStock Investor Pitch: Brain+
Brain+ is a health tech company focused on treatment and management of dementia. Centred around the Cognitive Stimulation Therapy method, the company’s approach has the potential to revolutionize dementia care. Brain+ is now raising capital to pursue commercialisation in the UK.
Watch Brain+‘s co-founder and CEO Kim Baden-Kristensen present the company here:
BioStock is a news service and does not provide investment advice, does not convey investment orders and assumes no responsibility for actions and/or any loss or damage of any kind based on the use of content posted on BioStock.se. Instead, each investment decision is made independently by the individual investor. The content of BioStock’s news is independent, but as BioStock’s operations are partly financed by companies in the industry, BioStock’s website may contain news about companies from which BioStock has received financing.
This material has been created for marketing purposes and is not and should not be considered a prospectus under applicable laws and regulations. The complete terms and conditions for the rights issue and more information about the company have been presented in a prospectus published on the above-mentioned company’s website.
